(Capcom's primary storyline)
Umbrella Europe was a loose collection of national holding companies for Umbrella, covering the European continent. At least six laboratories were under its jurisdiction. The continent was also the site for the global headquarters of the parent company, Umbrella Pharmaceuticals. Umbrella Europe is known to have been in competition with Umbrella U.S.A. in bio-weapons development.
The earliest known actions by Umbrella Europe was in response to the U.S.A. division's Dr. William Birkin, who was making significant breakthroughs with B.O.W.s such as the Hunter α. In order to best them, the European branches began working together to design their own counterparts, focusing on better enhancing the weapons' intelligence rather than the Americans' focus on enhanced strength.
Umbrella Europe crowning achievement was the Nemesis Project, which revolved around their 6th Laboratory's development of the NE-α Type ("Nemesis Alpha") parasite, an organism intended to retain intelligence and control over B.O.W.s by having it take over the host's nervous system. Because it was considered key by Umbrella U.S.A. in reaching the Third Stage of the t-Virus Project with their own Tyrant Project, in 1988 Umbrella U.S.A.'s Arklay Laboratory team - led by Dr. William Birkin - managed to get a hold of a parasite thanks to the backing-up of Oswell E. Spencer. The subsequent experimentation of the parasite by using their guinea-pig, Lisa Trevor, as its host proved shocking to the team when her body's defences not only succeeded in killing the parasite, but added its genetic material to her own. This led to Umbrella U.S.A.'s development of the G-Virus. Umbrella Europe continued to work with Umbrella U.S.A. regarding their Nemesis Program when a parasite was implanted within a T-103 Tyrant model, successfully merging the two project's aims into a single being - the Nemesis-T Type. A fax sent from Umbrella Europe's No.6 Laboratory to a small Umbrella U.S.A. branch asked for a delivery of the chemical "VT-J98", which was deemed necessary for the cultivation of their other parasites.
At some point in the 1990s, Umbrella Europe managed to acquire data into Umbrella U.S.A.'s Hunter program, formerly led by Dr. William Birkin. With this data they engineered the Hunter γ, having taken a radical divergence by using amphibian DNA as opposed to reptilian. Umbrella U.S.A. acquired some of these models by around mid-1998, storing specimens underneath both the Raccoon General Hospital and Raccoon University.
In December 1998, Claire Redfield travelled to Europe in search of her brother, Chris Redfield, who had made plans with Barry Burton and Jill Valentine to investigate Umbrella HQ. Breaching their Paris facility, she was eventually captured by their PrivSol team.
- ↑ Capcom. Resident Evil: The Umbrella Chronicles. (Capcom). File: Talos Project Proposal.
- ↑ Capcom Production Studio 4. Resident Evil 3: Nemesis. (Capcom). File: Business Fax.
- ↑ Capcom. Resident Evil: The Darkside Chronicles. (Capcom). File: Hunter γ.
- ↑ バイオハザード3～Last Escape～／CREATURES (Japanese). Capcom. Retrieved on 2012-08-31.